Novartis Seeks Too Much In Attys' Fees In IP Row, NPE Says
A defunct non-practicing entity found to have engaged in an "exceptional" case involving a web-based patent that was ultimately invalidated fought back on Monday against Novartis' detailing of the attorneys' fees...To view the full article, register now.
Already a subscriber? Click here to view full article